Variant report
Variant | nsv979374 |
---|---|
Chromosome Location | chr2:125107084-125122261 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556478399 | chr2:125107130-125107131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576702441 | chr2:125107131-125107132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568231702 | chr2:125107151-125107152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35336415 | chr2:125107199-125107200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536142441 | chr2:125107223-125107224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181129177 | chr2:125107228-125107229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142943197 | chr2:125107297-125107298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184615607 | chr2:125107351-125107352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560294828 | chr2:125107371-125107372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148679950 | chr2:125107437-125107438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576972552 | chr2:125107438-125107439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377160715 | chr2:125107446-125107447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369557565 | chr2:125107447-125107448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374509781 | chr2:125107451-125107452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs70996061 | chr2:125107452-125107453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75965299 | chr2:125107480-125107481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545522464 | chr2:125107500-125107501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113536401 | chr2:125107508-125107509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531538421 | chr2:125107520-125107521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150665665 | chr2:125107524-125107525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139830368 | chr2:125107565-125107566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34117183 | chr2:125107574-125107575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs386650002 | chr2:125107577-125107578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372577571 | chr2:125107578-125107579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570619207 | chr2:125107636-125107637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs60854804 | chr2:125107702-125107703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111245470 | chr2:125107706-125107707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576777428 | chr2:125107755-125107756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549735944 | chr2:125107758-125107759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535449339 | chr2:125107764-125107765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368234764 | chr2:125107918-125107919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7567224 | chr2:125107948-125107949 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs566332207 | chr2:125108001-125108002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs779999 | chr2:125108025-125108026 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs372122951 | chr2:125108030-125108031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71641606 | chr2:125108031-125108032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187642792 | chr2:125108050-125108051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs779998 | chr2:125108051-125108052 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs76777282 | chr2:125108052-125108053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545863336 | chr2:125108073-125108074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191957724 | chr2:125108085-125108086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576002748 | chr2:125108122-125108123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561354065 | chr2:125108150-125108151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181009838 | chr2:125108162-125108163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539449373 | chr2:125108189-125108190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs796641 | chr2:125108191-125108192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs11378065 | chr2:125108208-125108209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140247591 | chr2:125108311-125108312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115983630 | chr2:125108342-125108343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7582767 | chr2:125108364-125108365 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:125105200-125108800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:125108800-125109000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:125108800-125109600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:125109600-125109800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr2:125119400-125119800 | Active TSS | H9 Cell Line | embryonic stem cell |
6 | chr2:125119600-125120000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
7 | chr2:125119600-125120000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
8 | chr2:125119600-125120000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr2:125120000-125120200 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |